SEB Asset Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
BBA
SEB Asset Management's EWTX Position: Q3 2026 in Review
SEB Asset Management increased its Edgewise Therapeutics (EWTX) stake by 24% in Q3 2026, buying an estimated $2.02M and bringing the position to 241,488 shares worth $9.8M. The position accounts for 0.04% of the portfolio, ranked #329.
SEB Asset Management first reported a position in EWTX in Q1 2026 and has held it in 3 quarters since. 252 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.
- SEB Asset Management held 241,488 shares of Edgewise Therapeutics worth $9.8M as of Q3 2026.
- SEB Asset Management bought 47,425 Edgewise Therapeutics shares in Q3 2026, an estimated $2.02M.
- Edgewise Therapeutics made up 0.04% of SEB Asset Management's portfolio in Q3 2026, its #329 holding.
- SEB Asset Management first reported a position in Edgewise Therapeutics in Q1 2026 and has held it in 3 quarters since.
- 252 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.